For the time being, anyone seeking a COVID-19 vaccine have either the Moderna or Pfizer offerings to choose from as the Johnson and Johnson will be withheld after blood clotting was reported as a potential side effect.
According to the CDC, the organization and the FDA are reviewing six cases of what is described as a “rare and severe type of blood clot” occurring in people who received the vaccine. The blood clots occurred in women aged 18-49 and occurred between six and 13 days after vaccination.
“Treatment of this specific type of blood clot is different from the treatment that might typica...
Reader Comments(0)